Royal Bank of Canada Has Lowered Expectations for Pliant Therapeutics (NASDAQ:PLRX) Stock Price
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target decreased by equities research analysts at Royal Bank of Canada from $4.00 to $3.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price indicates a potential upside of […]
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target decreased by equities research analysts at Royal Bank of Canada from $4.00 to $3.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price indicates a potential upside of […]
